Barclays’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
449
-31,670
| -99% | -$70.5K | ﹤0.01% | 4296 |
|
|
2025
Q1 | $47K | Sell |
32,119
-15,827
| -33% | -$23.2K | ﹤0.01% | 3903 |
|
|
2024
Q4 | $100K | Buy |
47,946
+5,913
| +14% | +$12.3K | ﹤0.01% | 3793 |
|
|
2024
Q3 | $74K | Buy |
42,033
+30,213
| +256% | +$53.2K | ﹤0.01% | 3813 |
|
|
2024
Q2 | $171K | Sell |
11,820
-60,450
| -84% | -$875K | ﹤0.01% | 3126 |
|
|
2024
Q1 | $1.2M | Buy |
72,270
+32,362
| +81% | +$538K | ﹤0.01% | 2271 |
|
|
2023
Q4 | $640K | Buy |
39,908
+33,534
| +526% | +$538K | ﹤0.01% | 2865 |
|
|
2023
Q3 | $86K | Buy |
6,374
+375
| +6% | +$5.06K | ﹤0.01% | 3376 |
|
|
2023
Q2 | $102K | Sell |
5,999
-2,869
| -32% | -$48.8K | ﹤0.01% | 3390 |
|
|
2023
Q1 | $147K | Buy |
8,868
+4,180
| +89% | +$69.3K | ﹤0.01% | 3328 |
|
|
2022
Q4 | $79K | Buy |
4,688
+4,139
| +754% | +$69.7K | ﹤0.01% | 3596 |
|
|
2022
Q3 | $9K | Sell |
549
-101
| -16% | -$1.66K | ﹤0.01% | 4230 |
|
|
2022
Q2 | $7K | Buy |
+650
| New | +$7K | ﹤0.01% | 4409 |
|